Related Experiment Video
Updated: Feb 20, 2026

10:10
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
Published on: May 28, 2017
8.9K
Ecotropic Viral Integration Site 5 (EVI5) expression analysis in multiple sclerosis patients
Mehrdokht Mazdeh1,2, Mahnoosh Rahimi3, Mohammad Mahdi Eftekharian1
1Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Human Antibodies
|October 18, 2017
Summary
This study found no significant difference in Ecotropic Viral Integration Site 5 (EVI5) gene expression in the blood of multiple sclerosis (MS) patients compared to healthy individuals. Further research is needed to understand EVI5's role in MS.
Area of Science:
- Neuroimmunology
- Genetics
- Molecular Biology
Background:
- Multiple sclerosis (MS) is an immune-mediated central nervous system disorder involving T cell dysregulation.
- Genetic variants in the Ecotropic Viral Integration Site 5 (EVI5) gene are associated with MS susceptibility.
- Limited data exists on EVI5 gene expression levels in MS patients.
Purpose of the Study:
- To investigate the relative expression of the EVI5 gene in peripheral blood of MS patients versus healthy controls.
- To determine if EVI5 expression correlates with clinical parameters in MS.
Main Methods:
- Quantitative real-time RT-PCR was used to measure EVI5 gene expression.
- The study included 50 Iranian MS patients and healthy controls.
- Expression levels were compared between groups and correlated with disease duration, age at onset, and EDSS.
Main Results:
- No statistically significant difference in EVI5 relative expression was observed between MS patients and healthy controls.
- A trend towards significance was noted in patients aged 30-40 years.
- EVI5 expression did not correlate with disease duration, age at onset, or EDSS.
Conclusions:
- The study did not find a significant difference in EVI5 expression in MS patients.
- Further investigation is required to elucidate the role of EVI5 in the pathogenesis of multiple sclerosis.

